Results 211 to 220 of about 46,577 (260)

Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives [PDF]

Giuseppe Gaetano Loscocco, Paola Guglielmelli   +1 more
openalex   +1 more source

Quantitative MRI Assessment of Bone Marrow Disease in Myelofibrosis: A Prospective Study. [PDF]

Radiol Imaging Cancer
Robison TH, Levinson A, Lee W, Pettit K, Malyarenko D, Kandarpa M, Johnson TD, Chenevert TL, Ross BD, Talpaz M, Luker GD.   +10 more
europepmc   +1 more source

Optical genome mapping in myelofibrosis: enhancing prognostic accuracy through high-resolution genomic profiling. [PDF]

Blood Adv
Díaz-González Á, Mora E, Garrote M, Carreño-Tarragona G, Salido M, Pastor-Galán I, Stuckey R, Cisneros A, Domingo-Monfort JA, Uresandi-Iruin N, Argoitia-Ituarte N, Avetisyan G, García-Ruiz C, Torres-Hernández N, Furió S, Arellano-Rodrigo E, Álvarez N, Vélez P, Villamón E, Segura-Díaz A, Ayala R, Espinet B, Álvarez-Larrán A, Hernández-Boluda JC, Such E.   +24 more
europepmc   +1 more source

Case Report: Late Hypersensitivity Reaction to Hydroxyurea in a Patient With Myeloproliferative Disorder. [PDF]

Case Rep Hematol
Kahlon N, Baddam S, Kaur H, Singh P, Qureshi Z, Gowda AM.   +5 more
europepmc   +1 more source

Machine learning identifies inflammation-related diagnostic biomarkers for primary myelofibrosis with clinical validation. [PDF]

Sci Rep
Li R, Han Q, Zeng T, Wen B, Zheng Z, Bao X, Huang J.   +6 more
europepmc   +1 more source

Gender influences prognosis of classical BCR::ABL1 negative myeloproliferative neoplasms: a retrospective cohort study. [PDF]

Discov Oncol
Cai Y, Wang Y, Zhang P, Zhu Z.
europepmc   +1 more source

The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis [PDF]

Boque, Concepción, Gómez, Montse, Hernández Boluda, Juan Carlos, Luño Fernández, Elisa, Pereira, Arturo   +4 more
core   +1 more source

Treatment-relevant misdiagnosis of autoimmune myelofibrosis. [PDF]

Haematologica
Gangat N, Reichard KK, Orazi A, Viswanatha DS, Hanson CA, Tefferi A.   +5 more
europepmc   +1 more source

Supplementary Figure S3 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

John Mascarenhas, Anna Ritá Migliaccio, Heidi Kosiorek, Rupali Bhave, Jeanne Palmer, Andrew Kuykendall, Ruben A. Mesa, Raajit K. Rampal, Aaron T. Gerds, Abdulraheem Yacoub, Kristen Pettit, Moshe Talpaz, Rami S. Komrokji, Marina Kremyanskaya, Agapito Gonzalez, Frank Fabris, Kathryn Johnson, Mikaela Dougherty, Erin McGovern, Juan Arango Ossa, Dylan Domenico, Noushin Farnoud, Rona Singer Weinberg, Amy Kong, Vesna Najfeld, Alessandro M. Vannucchi, Francesca Arciprete, Maria Zingariello, Mario Falchi, Mohamed E. Salama, Carolyn Mead‐Harvey, Amylou C. Dueck, Lilian Varricchio, Ronald Hoffman   +33 more
openalex   +1 more source

Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic Myelofibrosis. [PDF]

Cancers (Basel)
Machherndl-Spandl S, Kiehberger M, Sygulla V, Kaynak E, Zach O, Webersinke G, Gruber-Rossipal C, Beham-Schmid C, Maier E, Strassl I, Clausen J, Nikoloudis A, Schimetta W, Rumpold H, Buxhofer-Ausch V.   +14 more
europepmc   +1 more source